Found: 57
Select item for more details and to access through your institution.
Management of antineutrophil cytoplasmic antibody–associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 11, p. 2637, doi. 10.1093/ndt/gfad090
- By:
- Publication type:
- Article
Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 11, p. 2190, doi. 10.1093/ndt/gfab357
- By:
- Publication type:
- Article
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 8, p. 1400, doi. 10.1093/ndt/gfac052
- By:
- Publication type:
- Article
Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
- Published in:
- Nephrology Dialysis Transplantation, 2019, v. 34, n. 2, p. 301, doi. 10.1093/ndt/gfy106
- By:
- Publication type:
- Article
Falling through the cracks of vasculitis classification—a report of three patients.
- Published in:
- NDT Plus, 2011, v. 4, n. 5, p. 327
- By:
- Publication type:
- Article
Renal Involvement of CD20-Negative Intravascular Large B Cell Lymphoma with Neurological Manifestations.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Correction to: Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes.
- Published in:
- Clinical Rheumatology, 2019, v. 38, n. 8, p. 2195, doi. 10.1007/s10067-019-04568-4
- By:
- Publication type:
- Article
A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
- Published in:
- Clinical Rheumatology, 2016, v. 35, n. 4, p. 953, doi. 10.1007/s10067-015-3086-8
- By:
- Publication type:
- Article
Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant.
- Published in:
- Transplant International, 2013, v. 26, n. 12, p. 1225, doi. 10.1111/tri.12203
- By:
- Publication type:
- Article
Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course.
- Published in:
- European Journal of Rheumatology, 2022, v. 9, n. 2, p. 93, doi. 10.5152/eujrheum.2022.20258
- By:
- Publication type:
- Article
Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic.
- Published in:
- European Journal of Rheumatology, 2020, v. 7, n. 2, p. S121, doi. 10.5152/eurjrheum.2020.2067
- By:
- Publication type:
- Article
Outcomes of hydralazine induced renal vasculitis.
- Published in:
- European Journal of Rheumatology, 2018, v. 5, n. 1, p. 46, doi. 10.5152/eurjrheum.2017.17075
- By:
- Publication type:
- Article
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1228457
- By:
- Publication type:
- Article
Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.
- Published in:
- ImmunoTargets & Therapy, 2015, v. 4, p. 173, doi. 10.2147/ITT.S55516
- By:
- Publication type:
- Article
Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 9, p. 1145, doi. 10.3899/jrheum.220851
- By:
- Publication type:
- Article
Challenges of defining renal response in ANCA-associated vasculitis: call to action?
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 6, p. 965, doi. 10.1093/ckj/sfad009
- By:
- Publication type:
- Article
Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis.
- Published in:
- Clinical Kidney Journal, 2017, v. 10, n. 4, p. 470, doi. 10.1093/ckj/sfx014
- By:
- Publication type:
- Article
Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4654, doi. 10.1093/rheumatology/keab071
- By:
- Publication type:
- Article
315. Use of subcutaneous IGG to treat hypogammaglobinemia in ANCA-associated vasculitis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
253. Outcomes in elderly patients with ANCA-associated glomerulonephritis.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
093. Atypical presentation of ANCA-associated vasculitis: A case series.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives.
- Published in:
- Kidney & Blood Pressure Research, 2020, v. 45, n. 2, p. 157, doi. 10.1159/000505660
- By:
- Publication type:
- Article
Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome.
- Published in:
- Current Rheumatology Reports, 2024, v. 26, n. 8, p. 290, doi. 10.1007/s11926-024-01150-z
- By:
- Publication type:
- Article
Study protocol of a randomized controlled trial of fistula vs. graft arteriovenous vascular access in older adults with end-stage kidney disease on hemodialysis: the AV access trial.
- Published in:
- BMC Nephrology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12882-023-03086-5
- By:
- Publication type:
- Article
Outcomes of remission induction therapy for ANCA-associated vasculitis in the elderly.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 9, p. 2427, doi. 10.1007/s10067-023-06644-2
- By:
- Publication type:
- Article
Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1888, doi. 10.1002/art.41017
- By:
- Publication type:
- Article
Treatment Outcomes of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Patients Over Age 75 Years: A Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Treatment of Severe Renal Disease in ANCA Positive and Negative Small Vessel Vasculitis with Rituximab.
- Published in:
- American Journal of Nephrology, 2015, v. 41, n. 4/5, p. 296, doi. 10.1159/000431336
- By:
- Publication type:
- Article
Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Antineutrophil Cytoplasmic Antibody Vasculitis Associated with Influenza Vaccination.
- Published in:
- American Journal of Nephrology, 2013, v. 38, n. 2, p. 174, doi. 10.1159/000354084
- By:
- Publication type:
- Article
ANCA Status or Clinical Phenotype — What Counts More?
- Published in:
- Current Rheumatology Reports, 2021, v. 23, n. 6, p. 1, doi. 10.1007/s11926-021-01002-0
- By:
- Publication type:
- Article
Advances in Therapy for ANCA-Associated Vasculitis.
- Published in:
- Current Rheumatology Reports, 2012, v. 14, n. 6, p. 509, doi. 10.1007/s11926-012-0284-0
- By:
- Publication type:
- Article
Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature.
- Published in:
- Clinical Transplantation, 2000, v. 14, n. 6, p. 586, doi. 10.1034/j.1399-0012.2000.140612.x
- By:
- Publication type:
- Article
Anti‐glomerular basement membrane disease (Goodpasture disease): From pathogenesis to plasma exchange to IdeS.
- Published in:
- Therapeutic Apheresis & Dialysis, 2022, v. 26, n. 1, p. 24, doi. 10.1111/1744-9987.13718
- By:
- Publication type:
- Article
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS–CoV‐2 Messenger RNA Vaccination.
- Published in:
- Arthritis & Rheumatology, 2022, v. 74, n. 1, p. 28, doi. 10.1002/art.41924
- By:
- Publication type:
- Article
COVID vaccine–induced lupus nephritis: Case report and review of the literature.
- Published in:
- Lupus, 2024, v. 33, n. 2, p. 176, doi. 10.1177/09612033231222390
- By:
- Publication type:
- Article
Factors mediating cancer risk in systemic lupus erythematosus.
- Published in:
- Lupus, 2022, v. 31, n. 11, p. 1285, doi. 10.1177/09612033221122163
- By:
- Publication type:
- Article
New-onset lupus nephritis associated with COVID-19 infection.
- Published in:
- Lupus, 2022, v. 31, n. 8, p. 1007, doi. 10.1177/09612033221098571
- By:
- Publication type:
- Article
Omeprazole-Induced Acute Interstitial Nephritis.
- Published in:
- 1999
- By:
- Publication type:
- Letter
Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritis.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Characterization of interstitial infiltrates in MPO and PR3 anti-neutrophil cytoplasmic antibody glomerulonephritis.
- Published in:
- Journal of Nephrology (JNonline), 2022, v. 35, n. 4, p. 1171, doi. 10.1007/s40620-021-01126-7
- By:
- Publication type:
- Article
Serum and urinary metabolites discriminate disease activity in ANCA associated glomerulonephritis in a pilot study.
- Published in:
- Journal of Nephrology (JNonline), 2022, v. 35, n. 2, p. 657, doi. 10.1007/s40620-021-01095-x
- By:
- Publication type:
- Article
The impact of COVID-19 pandemic on patients with ANCA associated vasculitis.
- Published in:
- Journal of Nephrology (JNonline), 2021, v. 34, n. 1, p. 185, doi. 10.1007/s40620-020-00881-3
- By:
- Publication type:
- Article
Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis.
- Published in:
- Journal of Nephrology (JNonline), 2017, v. 30, n. 1, p. 147, doi. 10.1007/s40620-015-0253-6
- By:
- Publication type:
- Article
Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
- Published in:
- Journal of Nephrology (JNonline), 2016, v. 29, n. 2, p. 195, doi. 10.1007/s40620-015-0208-y
- By:
- Publication type:
- Article
Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab.
- Published in:
- Journal of Nephrology (JNonline), 2015, v. 28, n. 1, p. 17, doi. 10.1007/s40620-014-0135-3
- By:
- Publication type:
- Article